Department of Radiation Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
Department of Diagnostic Radiology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
Oral Oncol. 2014 Mar;50(3):228-33. doi: 10.1016/j.oraloncology.2013.12.005. Epub 2014 Jan 6.
To investigate the prognostic value of prepontine cistern invasion (PPCI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT).
Five hundred and four non-disseminated NPC patients who underwent magnetic resonance imaging examination before radical IMRT between November 2000 and December 2008 were retrospectively reviewed. The diagnostic criteria for PPCI were tumor invasion through the posterior cortex of clivus and extension into the prepontine cistern.
The median follow-up of the patients in this study was 63.5 months. PPCI was found in 44 patients (25% of T4 patients). The 5-year progression-free survival (PFS), local control (LC), distant metastasis-free survival (DMFS), and overall survival (OS) of all patients, with and without PPCI, were 44.3% and 70.5% (p<0.001), 84.4% and 89.1% (p=0.376), 66.6% and 87.3% (p<0.001), and 59.6% and 80.2% (p<0.001), respectively. In T4 patients with PPCI and without PPCI, the 5-year PFS, LC, DMFS, and OS were 44.3% and 62.5% (p=0.023), 84.4% and 84.9% (p=0.946), 66.6% and 83.1% (p=0.022), and 59.6% and 71.0% (p=0.045), respectively. Using multivariate analysis, PPCI was found to be an independent poor prognostic factor for PFS (HR=1.816; p=0.007), DMFS (HR=1.928; p=0.045), and OS (HR=1.798; p=0.016).
Prepontine cistern invasion was an independent prognostic factor for poor DMFS and OS but not LC in NPC patients treated with IMRT, even within T4 patients.
研究前池侵犯(PPCI)对接受调强放疗(IMRT)的鼻咽癌(NPC)患者的预后价值。
回顾性分析 2000 年 11 月至 2008 年 12 月期间 504 例接受根治性 IMRT 前接受磁共振成像检查的非转移性 NPC 患者。PPCI 的诊断标准为肿瘤通过斜坡后皮质侵犯并延伸至桥前池。
本研究患者的中位随访时间为 63.5 个月。44 例(25%的 T4 患者)发现 PPCI。所有患者和无 PPCI 的患者的 5 年无进展生存率(PFS)、局部控制率(LC)、无远处转移生存率(DMFS)和总生存率(OS)分别为 44.3%和 70.5%(p<0.001)、84.4%和 89.1%(p=0.376)、66.6%和 87.3%(p<0.001)和 59.6%和 80.2%(p<0.001)。在有和没有 PPCI 的 T4 患者中,5 年 PFS、LC、DMFS 和 OS 分别为 44.3%和 62.5%(p=0.023)、84.4%和 84.9%(p=0.946)、66.6%和 83.1%(p=0.022)和 59.6%和 71.0%(p=0.045)。多因素分析发现,PPCI 是 PFS(HR=1.816;p=0.007)、DMFS(HR=1.928;p=0.045)和 OS(HR=1.798;p=0.016)的独立不良预后因素。
即使在 T4 患者中,桥前池侵犯也是接受 IMRT 的 NPC 患者不良 DMFS 和 OS 的独立预后因素,但不是 LC 的独立预后因素。